#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Stress cardiomyopathy Pyoderma gangrenosum Necrotising enterocolitis neonatal Neovascular age-related macular degeneration B-cell small lymphocytic lymphoma Acute graft versus host disease in skin Malignant central nervous system neoplasm Precursor T-lymphoblastic lymphoma/leukaemia recurrent Choroid melanoma Acute hepatic failure Emphysema Marfan's syndrome Eosinophilic granulomatosis with polyangiitis Cardiac amyloidosis Squamous cell carcinoma of the hypopharynx More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma metastatic – Basic Information Glomerulonephritis rapidly progressive Small intestine leiomyosarcoma – Basic Information Carcinoid syndrome – Trials in Disease Basal cell naevus syndrome – Life with Disease Chordoma – Treatment Soft tissue sarcoma – Trials in Disease Breast angiosarcoma metastatic – Basic Information Angiosarcoma Friedreich’s ataxia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Rbl035.2 Ixazomib Citrate GSKVX000000070965 Avatrombopag LY3537031 Alternaria Alternata (402) LINAPRAZAN GLURATE Pralatrexate 19Cp02 Eftrenonacog Alfa Rosnilimab Serpina1(Human)-Aav8-1 Liraglutide Ponatinib Pantoprazole C1 Esterase Inhibitor (Human) Sodium Lactate Solution Oseltamivir Etrinabdione Tusamitamab Ravtansine More therapies…

    Learn about Your Condition

    Soft tissue sarcoma Bacterial vaginosis Chronic sinusitis Acute HIV infection Pancoast's tumour Congenital ureteric anomaly Dermatitis Wolfram syndrome Angiosarcoma non-metastatic Nocturia Metastases to rectum Traumatic pain Metabolic syndrome Muscle injury Ovarian cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Breast cancer metastatic

  • Study of Paclitaxel, Carboplatin, and Durvalumab with or without Oleclumab for Patients with Untreated Advanced Triple-Negative Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Breast cancer recurrent
    • Breast cancer metastatic
    • Triple negative breast cancer
    Investigated Drugs:
    • Oleclumab
    • Carboplatin
    • Durvalumab
    Belgium France

  • Study of PF-07220060 and PF-07104091 with Endocrine Therapy for Patients with Advanced HR-positive HER2-negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • [(1R,3S)-3-[3-[[5-(Methoxymethyl)-2-Methylpyrazole-3-Carbonyl]Amino]-1H-Pyrazol-5-Yl]Cyclopentyl]N-Propan-2-Ylcarbamate Monohydrate
    • Pf-07220060 Monohydrate
    • Letrozole
    Bulgaria Czechia Spain

  • Study on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Pf-07220060 Monohydrate
    • Letrozole
    • Fulvestrant
    Czechia Slovakia

  • Study of inavolisib, palbociclib and fulvestrant in patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    Investigated Drugs:
    • Inavolisib
    • Palbociclib
    • Fulvestrant
    Belgium France Germany Greece Hungary Italy +3

  • Study on Detecting Untreated Brain Metastases in Lung, Breast, and Melanoma Cancer Patients Using Fluorodopa (18F)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Metastatic malignant melanoma
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Fluorodopa (18F)
    France

  • Study of Fulvestrant and Samuraciclib for Patients with Advanced HR Positive, HER2-Negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Samuraciclib
    • Fulvestrant
    Hungary Spain
Previous Page
1 … 9 10 11 12 13 14
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!